Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.

Abstract:

:The present work is a continuation of our studies to improve the graft versus leukemia (GVL) effect in autologous bone marrow transplantation. We have recently shown that the GVL effect of bone marrow transplantation (BMT) with interleukin 2 (IL-2)-activated bone marrow (ABM) followed by IL-2 therapy immediately after BMT is superior to the GVL effect of BMT with fresh, syngeneic bone marrow, with or without IL-2 therapy, in mice with acute myeloid leukemia. The present studies show that institution of IL-2 treatment 1, 2, or 3 weeks after BMT with ABM resulted in shortening of survival and fall in cure rate as compared to IL-2 therapy instituted immediately after BMT with ABM. Increasing the dose of IL-2 did not improve results. However, reducing the frequency of IL-2 administration to once a day instead of twice a day affected the results adversely. Commencing IL-2 therapy 1, 2, or 3 weeks after BMT with fresh, syngeneic bone marrow did not improve the GVL effect as compared to IL-2 therapy started immediately after BMT with fresh, syngeneic bone marrow. Cryopreserved bone marrow was effectively activated with IL-2 and used successfully for BMT after thawing. The animals cured of leukemia by BMT with ABM and and IL-2 therapy were not resistant to leukemia and died when reinfused with leukemic cells. Our findings suggest that for optimum GVL effect, activation of bone marrow is necessary and IL-2 therapy should be started immediately after BMT with ABM.

journal_name

Cancer Res

journal_title

Cancer research

authors

Charak BS,Brynes RK,Katsuda S,Groshen S,Chen SC,Mazumder A

subject

Has Abstract

pub_date

1991-04-15 00:00:00

pages

2015-20

issue

8

eissn

0008-5472

issn

1538-7445

journal_volume

51

pub_type

杂志文章
  • Tumor-promoting phorbol diester-induced specific changes in cell surface glycoprotein profile of K562 human leukemic cells.

    abstract::The tumor-promoting phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), induced specific changes in the cell surface glycoprotein profile of K562 human leukemic cells. TPA-treated K562 cells were examined by cell surface labeling followed by immunoprecipitation with anti-glycophorin antiserum or anti-K562 antis...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fukuda M

    更新日期:1981-11-01 00:00:00

  • Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells.

    abstract::Bortezomib (PS-341), a selective inhibitor of proteasome, induces apoptosis in various tumor cells, but its mechanism of action is unclear. Treatment with PS-341 induces apoptosis in SUDHL6 (DHL6), but not SUDHL4 (DHL4), lymphoma cells. Microarray analysis shows high RNA levels of heat shock protein-27 (Hsp27) in DHL4...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chauhan D,Li G,Shringarpure R,Podar K,Ohtake Y,Hideshima T,Anderson KC

    更新日期:2003-10-01 00:00:00

  • Retinoic acid inhibition of the comitogenic action of mezerein and phorbol esters in bovine lymphocytes.

    abstract::12-O-Tetradecanoylphorbol-13-acetate (TPA) is an effective comitogen in phytohemagglutinin-treated bovine lymphocytes. Concurrent addition of 10(-8) M TPA gives a greater than 6-fold increase in DNA synthesis over cultures treated with the lectin alone. The delayed addition of phorbol ester, relative to the start of t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kensler TW,Mueller GC

    更新日期:1978-03-01 00:00:00

  • Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) are the major adult liver cancers. The existence of combined hepatocellular-cholangiocarcinoma (CHC), a histopathologic intermediate form between HCC and CC, suggests phenotypic overlap between these tumors. Here, we applied an integrative oncogenomic approach...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2823

    authors: Woo HG,Lee JH,Yoon JH,Kim CY,Lee HS,Jang JJ,Yi NJ,Suh KS,Lee KU,Park ES,Thorgeirsson SS,Kim YJ

    更新日期:2010-04-15 00:00:00

  • Trp53 inactivation in the tumor microenvironment promotes tumor progression by expanding the immunosuppressive lymphoid-like stromal network.

    abstract::Inactivation of the tumor suppressor p53 through somatic mutations, observed in 50% of human cancers, is one of the leading causes of tumorigenesis. Clinical and experimental evidence also reveals that p53 mutations sometimes occur in tumor-associated fibroblasts, which correlate with an increased rate of metastases a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-3810

    authors: Guo G,Marrero L,Rodriguez P,Del Valle L,Ochoa A,Cui Y

    更新日期:2013-03-15 00:00:00

  • Tubulin as a major cell surface protein in human lymphoid cells of leukemic origin.

    abstract::Surface-exposed proteins of vinblastine-sensitive human lymphoid cell line of leukemic origin (CCRF-CEM) were examined by the lactoperoxidase-catalyzed iodination and two-dimensional polyacrylamide gel electrophoresis methods. Spots which comigrate with bovine brain tubulin and rabbit muscle actin were prominently lab...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rubin RW,Quillen M,Corcoran JJ,Ganapathi R,Krishan A

    更新日期:1982-04-01 00:00:00

  • Unsaturated fatty acids are required for continuous proliferation of transformed androgen-dependent cells by fibroblast growth factor family proteins.

    abstract::Increase in dietary fat intake has been reported to be associated with progression of hormone-dependent cancers. To explore its mechanism, we examined the effects of fatty acids on the growth of androgen-dependent SC-3 cells cloned from mouse mammary cancer (Shionogi carcinoma 115). Their androgen-dependent growth was...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kasayama S,Koga M,Kouhara H,Sumitani S,Wada K,Kishimoto T,Sato B

    更新日期:1994-12-15 00:00:00

  • Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.

    abstract::Busulfan (1,4-butanediol dimethanesulfonate, BU) is relatively unique among other standard chemotherapy compounds in its ability to deplete noncycling primitive stem cells in the host and consequently to allow for high levels of long-term, donor-type engraftment after bone marrow transplantation (BMT). Such a property...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Westerhof GR,Ploemacher RE,Boudewijn A,Blokland I,Dillingh JH,McGown AT,Hadfield JA,Dawson MJ,Down JD

    更新日期:2000-10-01 00:00:00

  • Targeting leukemia-initiating cells in acute lymphoblastic leukemia (ALL).

    abstract::The concept that different leukemias are developmentally distinct and, like in normal hematopoiesis, generated by restricted populations of cells named leukemia-initiating cells (LIC), is becoming more established. These cancer stem-like cells have been assumed to have unique properties, including the capability of se...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-20-2571

    authors: Tamiro F,Weng AP,Giambra V

    更新日期:2021-01-07 00:00:00

  • A Federated Network for Translational Cancer Research Using Clinical Data and Biospecimens.

    abstract::Advances in cancer research and personalized medicine will require significant new bridging infrastructures, including more robust biorepositories that link human tissue to clinical phenotypes and outcomes. In order to meet that challenge, four cancer centers formed the Text Information Extraction System (TIES) Cancer...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-15-1973

    authors: Jacobson RS,Becich MJ,Bollag RJ,Chavan G,Corrigan J,Dhir R,Feldman MD,Gaudioso C,Legowski E,Maihle NJ,Mitchell K,Murphy M,Sakthivel M,Tseytlin E,Weaver J

    更新日期:2015-12-15 00:00:00

  • Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.

    abstract::Colorectal and lung cancers account for one-third of all cancer-related deaths worldwide. Previous studies suggested that Metadherin (MTDH) is involved in the development of colorectal and lung cancers. However, how MTDH regulates the pathogenesis of these cancers remains largely unknown. Using genetically modified mo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-1876

    authors: Shen M,Xie S,Rowicki M,Michel S,Wei Y,Hang X,Wan L,Lu X,Yuan M,Jin JF,Jaschinski F,Zhou T,Klar R,Kang Y

    更新日期:2020-11-25 00:00:00

  • Human lymphoblastoid cell lines as effector cells in mitogen-dependent and antibody-dependent cell-mediated lysis.

    abstract::Based on reports that both human and murine lymphoblastoid cell lines can effect lysis in antibody-dependent (ADCC) and mitogen-induced (MICC) cell-mediated cytotoxicity, 10 human lymphoblastoid cell lines were investigated for their ability to act as effector cells in these lytic reactions. Four cell lines promoted M...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jordan TF,Ferrone S,Pellegrino MA,Dennert G

    更新日期:1978-11-01 00:00:00

  • Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.

    abstract::An immunosuppressive peptide fraction was isolated by means of gel filtration, membrane partition, and ion-exchange chromatography from the sera of patients hospitalized for cancer. The resulting peptide fraction, which was heterogeneous as judged by high-voltage electrophoresis, was found to suppress both phytohemagg...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nimberg RB,Glasgow AH,Menzoian JO,Constantian MB,Cooperband SR,Mannick JA,Schmid K

    更新日期:1975-06-01 00:00:00

  • Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.

    abstract::Osimertinib, a mutant-specific third-generation EGFR tyrosine kinase inhibitor, is emerging as the preferred first-line therapy for EGFR-mutant lung cancer, yet resistance inevitably develops in patients. We modeled acquired resistance to osimertinib in transgenic mouse models of EGFRL858R -induced lung adenocarcinoma...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-3819

    authors: Starrett JH,Guernet AA,Cuomo ME,Poels KE,van Alderwerelt van Rosenburgh IK,Nagelberg A,Farnsworth D,Price KS,Khan H,Ashtekar KD,Gaefele M,Ayeni D,Stewart TF,Kuhlmann A,Kaech SM,Unni AM,Homer R,Lockwood WW,Michor F,G

    更新日期:2020-05-15 00:00:00

  • Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.

    abstract::Glioblastoma (GBM) is often treated with the cytotoxic drug temozolomide, but the disease inevitably recurs in a drug-resistant form after initial treatment. Here, we report that in GBM cells, even a modest decrease in the mismatch repair (MMR) components MSH2 and MSH6 have profound effects on temozolomide sensitivity...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3616

    authors: McFaline-Figueroa JL,Braun CJ,Stanciu M,Nagel ZD,Mazzucato P,Sangaraju D,Cerniauskas E,Barford K,Vargas A,Chen Y,Tretyakova N,Lees JA,Hemann MT,White FM,Samson LD

    更新日期:2015-08-01 00:00:00

  • APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.

    abstract::The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like APOBEC3A and APOBEC3B have emerged as key mutation drivers in cancer. Here, we show that APOBEC3A and APOBEC3B activities impose a unique type of replication stress by inducing abasic sites at replication forks. In contrast to cells under other types ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-3389

    authors: Buisson R,Lawrence MS,Benes CH,Zou L

    更新日期:2017-09-01 00:00:00

  • Growth enhancement of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar by estrogen or prolactin.

    abstract::Cells obtained from N-nitrosomethylurea-induced rat mammary tumors were grown in vitro using the soft-agar clonogenic assay technique. Their growth was studied in regular media containing serum as well as in media lacking serum, but to which insulin was added. Deletion of serum from the media resulted in a mean decrea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Arafah BM,Griffin P,Gordon NH,Pearson OH

    更新日期:1984-12-01 00:00:00

  • Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

    abstract::Evidence from pathology and epidemiology studies has been provided for a human model of gastric carcinogenesis with the following sequential stages: chronic gastritis; atrophy; intestinal metaplasia; and dysplasia. The initial stages of gastritis and atrophy have been linked to excessive salt intake and infection with...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Correa P

    更新日期:1992-12-15 00:00:00

  • Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.

    abstract::Antiestrogen resistance is frequently observed in patients after longterm treatment with tamoxifen, a nonsteroidal antiestrogen widely used for endocrine therapy of breast cancer. In vitro studies in resistant cells showed that the expression of natural estrogen-responsive genes is frequently altered. Using MVLN cells...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Badia E,Duchesne MJ,Semlali A,Fuentes M,Giamarchi C,Richard-Foy H,Nicolas JC,Pons M

    更新日期:2000-08-01 00:00:00

  • Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis.

    abstract::A monoclonal antibody (mAb), 50-6, generated by subtractive immunization, was found to specifically inhibit in vivo metastasis of a human epidermoid carcinoma cell line, HEp-3. The cDNA of the cognate antigen of mAb 50-6 was isolated by a modified eukaryotic expression cloning protocol from a HEp-3 library. Sequence a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Testa JE,Brooks PC,Lin JM,Quigley JP

    更新日期:1999-08-01 00:00:00

  • Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.

    abstract::Farnesol (FOH) and other isoprenoid alcohols induce apoptosis in various carcinoma cells and inhibit tumorigenesis in several in vivo models. However, the mechanisms by which they mediate their effects are not yet fully understood. In this study, we show that FOH is an effective inducer of apoptosis in several lung ca...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0931

    authors: Joo JH,Liao G,Collins JB,Grissom SF,Jetten AM

    更新日期:2007-08-15 00:00:00

  • The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis.

    abstract::KANSL2 is an integral subunit of the nonspecific lethal (NSL) chromatin-modifying complex that contributes to epigenetic programs in embryonic stem cells. In this study, we report a role for KANSL2 in regulation of stemness in glioblastoma (GBM), which is characterized by heterogeneous tumor stem-like cells associated...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-3159

    authors: Ferreyra Solari NE,Belforte FS,Canedo L,Videla-Richardson GA,Espinosa JM,Rossi M,Serna E,Riudavets MA,Martinetto H,Sevlever G,Perez-Castro C

    更新日期:2016-09-15 00:00:00

  • Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.

    abstract::Infection with Helicobacter pylori is a major cause of gastric cancer (GC). The association likely has been underestimated in the past due to disease-related clearance of the infection. On the other hand, only a minority of the infected individuals develop GC, and better risk stratification is therefore highly desirab...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0596

    authors: Gao L,Michel A,Weck MN,Arndt V,Pawlita M,Brenner H

    更新日期:2009-08-01 00:00:00

  • Antagonizing Integrin β3 Increases Immunosuppression in Cancer.

    abstract::Integrin β3 is critical for tumor invasion, neoangiogenesis, and inflammation, making it a promising cancer target. However, preclinical and clinical data of integrin β3 antagonists have demonstrated no benefit or worse outcomes. We hypothesized that integrin β3 could affect tumor immunity and evaluated tumors in mice...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-2663

    authors: Su X,Esser AK,Amend SR,Xiang J,Xu Y,Ross MH,Fox GC,Kobayashi T,Steri V,Roomp K,Fontana F,Hurchla MA,Knolhoff BL,Meyer MA,Morgan EA,Tomasson JC,Novack JS,Zou W,Faccio R,Novack DV,Robinson SD,Teitelbaum SL,DeNar

    更新日期:2016-06-15 00:00:00

  • Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR.

    abstract::We have used genome-wide allelotyping with 348 polymorphic autosomal markers spaced, on average, 10 cM apart to quantitate the extent of intrachromosomal instability in 59 human sporadic colorectal carcinomas. We have compared instability measured by this method with that measured by inter-(simple sequence repeat) PCR...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Anderson GR,Brenner BM,Swede H,Chen N,Henry WM,Conroy JM,Karpenko MJ,Issa JP,Bartos JD,Brunelle JK,Jahreis GP,Kahlenberg MS,Basik M,Sait S,Rodriguez-Bigas MA,Nowak NJ,Petrelli NJ,Shows TB,Stoler DL

    更新日期:2001-11-15 00:00:00

  • Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.

    abstract::Estrogen receptor (ER) agonists and antagonists elicit distinct responses in non-small cell lung cancer (NSCLC) cells. To determine how such responses are generated, the expression of ERalpha, ERbeta, and ER coregulators in human lung fibroblasts and human NSCLC cell lines was evaluated by immunoblot. Ligand-dependent...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2694

    authors: Hershberger PA,Vasquez AC,Kanterewicz B,Land S,Siegfried JM,Nichols M

    更新日期:2005-02-15 00:00:00

  • A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.

    abstract::The vast majority of patients with plasma cell neoplasms die of progressive disease despite high response rates to novel agents. Malignant plasma cells are very radiosensitive, but the potential role of radioimmunotherapy (RIT) in the management of plasmacytomas and multiple myeloma has undergone only limited evaluati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1589

    authors: Green DJ,Orgun NN,Jones JC,Hylarides MD,Pagel JM,Hamlin DK,Wilbur DS,Lin Y,Fisher DR,Kenoyer AL,Frayo SL,Gopal AK,Orozco JJ,Gooley TA,Wood BL,Bensinger WI,Press OW

    更新日期:2014-02-15 00:00:00

  • The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.

    abstract::Although aberrant microRNA (miRNA) is expressed in different types of human cancer tissues, its pathophysiologic role and the relevance of tumorigenesis and metastasis are still largely unknown. Here, we defined miRNAs involved in cancer metastasis (metastamirs) using an established mouse model for peritoneal dissemin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2530

    authors: Takei Y,Takigahira M,Mihara K,Tarumi Y,Yanagihara K

    更新日期:2011-02-15 00:00:00

  • Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.

    abstract::Human prostate cancer is associated with a reactive stroma typified by an increase in the proportion of myofibroblast type cells and elevated synthesis of extracellular matrix proteins. Increased vascular density has been identified in the reactive stroma compartment adjacent to both precancerous and cancerous prostat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McAlhany SJ,Ressler SJ,Larsen M,Tuxhorn JA,Yang F,Dang TD,Rowley DR

    更新日期:2003-09-15 00:00:00

  • Selective antitumor effect of novel protease-mediated photodynamic agent.

    abstract::A new approach to selective photodynamic therapy (PDT) was developed by designing chlorin e6 (Ce6)-containing macromolecules, which are sensitive to tumor-associated proteases. The agents are nontoxic in their native state but become fluorescent and produce singlet oxygen on protease conversion. Coupled with optimized...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0448

    authors: Choi Y,Weissleder R,Tung CH

    更新日期:2006-07-15 00:00:00